Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Adamas Pharmaceuticals Inc (ADMS) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/24/2020 3 Papapetropoulos Spyridon (Director) has filed a Form 3 on Adamas Pharmaceuticals Inc
09/01/2020 3 RICHO ANNA (Director) has filed a Form 3 on Adamas Pharmaceuticals Inc
09/17/2019 3 McFarlane Neil F. (CEO) has filed a Form 3 on Adamas Pharmaceuticals Inc
06/04/2019 3 Shreedhar Vijay (Chief Commercial Officer) has filed a Form 3 on Adamas Pharmaceuticals Inc
10/11/2017 3 Form 3 - Initial statement of beneficial ownership of securities:
09/22/2017 3 Prentiss Christopher B (Chief Accounting Officer) has filed a Form 3 on Adamas Pharmaceuticals Inc
07/06/2017 3 Form 3 - Initial statement of beneficial ownership of securities
05/05/2017 3 KING RICHARD (COO) has filed a Form 3 on Adamas Pharmaceuticals Inc
09/22/2016 3 BIGHAM MICHAEL (Director) has filed a Form 3 on Adamas Pharmaceuticals Inc
08/08/2016 3 Form 3 - Initial statement of beneficial ownership of securities
04/14/2016 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy